2973-58-2

Basic information

• Product Name: 2-BROMO-3-HYDROXY-4-METHOXYBENZALDEHYDE
• Synonyms: AKOS B028891;2-BROMO-3-HYDROXY-4-METHOXYBENZALDEHYDE;BroMovanin;2-BroMo-3-forMyl-6-Methoxyphenol;2-BroMo-3-hydroxy-p-anisaldehyde;NSC 12212;NSC 139143;2-BroMo-3-hydroxy-4-Methoxybenzaldehyde 97%
• CAS NO: 2973-58-2
• Molecular Formula: C₈H₇BrO₃
• Molecular Weight: 231.04
• Product Categories: Aromatic Aldehydes & Derivatives (substituted);Aldehydes;C8;Carbonyl Compounds;Aromatics;Intermediates
• Mol File: 2973-58-2.mol
• Article Data: 55

Chemical Properties

• Melting Point: 202-207 °C(lit.)
• Boiling Point: 289.5°Cat760mmHg
• Flash Point: 128.9°C
• Appearance: /
• Density: 1.653g/cm³
• Vapor Pressure: 0.00126mmHg at 25°C
• Refractive Index: 1.622
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• Solubility: Dichloromethane, Ethyl Acetate
• PKA: 7.71±0.15(Predicted)
• CAS DataBase Reference: 2-BROMO-3-HYDROXY-4-METHOXYBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-3-HYDROXY-4-METHOXYBENZALDEHYDE(2973-58-2)
• EPA Substance Registry System: 2-BROMO-3-HYDROXY-4-METHOXYBENZALDEHYDE(2973-58-2)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 2973-58-2(Hazardous Substances Data)

Usage

Chemical Properties

Off-White Solid

Uses

2-Bromo-3-hydroxy-4-methoxybenzaldehyde (2-Bromo-isovanillin) may be used in the preparation of:2-hydroxy-3-methoxybenzaldehyde semicarbazone (HMBS)2-cyclopentyl-7-methoxy-1-benzofuran-4-carbaldehyde3-(benzyloxy)-2-bromo-4-methoxybenzaldehydeIt may also be used as a starting material in the total synthesis of the following natural products:pareitroponedenbinobin(±)-codeine

General Description

2-Bromo-3-hydroxy-4-methoxybenzaldehyde, also known as 2-bromo-isovanillin, can be synthesized by the bromination of 3-hydroxy-4-methoxybenzaldehyde.

InChI:InChI=1/C8H7BrO3/c1-12-6-3-2-5(4-10)7(9)8(6)11/h2-4,11H,1H3

Upstream product

• 621-59-0 isovanillin 
• 7726-95-6 bromine 
• 64-19-7 acetic acid 
• 115961-42-7 2-bromo-3-(methoxymethoxy)-4-methoxybenzaldehyde 
• 1315613-93-4 2-bromo-3-(1,3-dioxolan-2-ylmethyl)-6-methoxyphenol 
• 1315613-92-3 C₁₂H₁₅BrO₄ 
• 1315614-03-9 (4S, 6aS, 11bR)-11-(1,3-dioxolan-2-ylmethyl)-8-methoxy-3-methyl-2,3,4,5-tetra-hydro-1H-4,11b-methano[1]benzofuro[3,2-d]azocin-6-one 
• 1315614-02-8 tert-butyl 2-((5aS,9aS)-1-((1,3-dioxolan-2-yl)methyl)-4-methoxy-6-oxo-5a,6,9,9a-tetrahydrodibenzo[b,d]furan-9a-yl)ethyl(methyl)carbamate 
• 1315614-00-6 tert-butyl 2-((5aS,6S,9aR)-1-((1,3-dioxolan-2-yl)methyl)-6-hydroxy-4-methoxy-5a,6,9,9a-tetrahydrodibenzo[b,d]furan-9a-yl)ethyl(methyl)carbamate 
• 1315613-96-7 tert-butyl 2-((5'S,6'S)-6'-(3''-((1,3-dioxolan-2-yl)methyl)-2''-bromo-6''-methoxyphenoxy)-5'-(tert-butyldimethylsilyloxy)cyclohex-1'-enyl)ethyl(methyl)carbamate 
• 312920-40-4 (S)-(-)-methyl 6-(2-bromo-3-formyl-6-methoxyphenoxy)-cyclohex-1-enecarboxylate 
• 55171-60-3 2-bromo-3,4-dimethoxybenzylaldehyde 
• 6346-05-0 3-benzyloxy-4-methoxybenzaldehyde 

Downstream Products

• 109962-92-7 1-(2-bromo-3-hydroxy-4-methoxy-phenyl)-ethanol 
• 2459-83-8 2-Bromo-3-hydroxy-4-methoxybenzyl Alcohol 
• 90221-61-7 2-bromo-3-hydroxy-4-methoxybenzoic acid 
• 129103-68-0 2-bromo-6-methoxy-3-methyl-phenol 
• 144318-29-6 2-Bromo-6-methoxy-3-((E)-2-phenylsulfanyl-vinyl)-phenol 
• 107345-55-1 2-bromo-3-<(2-methylprop-2-enyl)oxy>-4-methoxybenzaldehyde 
• 185407-03-8 2-Bromo-3-(cyclohexan-2-en-1-oxy)-4-methoxy-benzaldehyde 
• 137718-76-4 N-methyl-2-bromo-3-hydroxy-4-methoxybenzenemethanamine 
• 93710-50-0 2-bromo-3-isopropoxy-4-methoxybenzaldehyde 
• 84284-73-1 2-(4'-benzyloxyphenyl)-7-methoxybenzofuran-4-carbaldehyde 
• 164228-28-8 2-bromo-3-((tert-butyldimethylsilyl)oxy)-4-methoxybenzaldehyde 
• 238749-58-1 7-methoxy-2-phenethyl-benzofuran-4-yl carbaldehyde 
• 185407-43-6 2-benzyl-7-methoxy-benzofuran-4-yl carbaldehyde 
• 263406-16-2 5-(2-bromo-3-formyl-6-methoxy-phenoxy)-3,4,5,6,7,8-hexahydro-1H-isoquinoline-2-carboxylic acid ethyl ester 

Relevant articles and documents

Quinazolinone compounds as well as preparation method and application thereof

The invention relates to quinazolinone compounds as well as a preparation method and application thereof, three kinases of EGFR (epidermal growth factor receptor), VEGFR-2 (vascular endothelial growthfactor receptor 2) and FGFR1 (fibroblast growth factor

SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES

The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3, R4, R5, R6 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.

Discovery of Novel Bromophenol-Thiosemicarbazone Hybrids as Potent Selective Inhibitors of Poly(ADP-ribose) Polymerase-1 (PARP-1) for Use in Cancer

Poly(ADP-ribose) polymerase-1 (PARP-1) is a new potential target for anticancer drug discovery. A series of bromophenol-thiosemicarbazone hybrids as PARP-1 inhibitors were designed, synthesized, and evaluated for their antitumor activities. Among them, the most promising compound, 11, showed excellent selective PARP-1 inhibitory activity (IC50 = 29.5 nM) over PARP-2 (IC50 > 1000 nM) and potent anticancer activities toward the SK-OV-3, Bel-7402 and HepG2 cancer cell lines (IC50 = 2.39, 5.45, and 4.60 μM), along with inhibition of tumor growth in an in vivo SK-OV-3 cell xenograft model. Further study demonstrated that compound 11 played an antitumor role through multiple anticancer mechanisms, including the induction of apoptosis and cell cycle arrest, cellular accumulation of DNA double-strand breaks, DNA repair alterations, inhibition of H2O2-triggered PARylation, antiproliferative effects via the production of cytotoxic reactive oxygen species, and autophagy. In addition, compound 11 displayed good pharmacokinetic characteristics and favorable safety. These observations demonstrate that compound 11 may serve as a lead compound for the discovery of new anticancer drugs.